These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 10362115

  • 1. Phase I study of a biweekly schedule of a fixed dose of cisplatin with increasing doses of paclitaxel in patients with advanced oesophageal cancer.
    van der Gaast A, Kok TC, Kerkhofs L, Siersema PD, Tilanus HW, Splinter TA.
    Br J Cancer; 1999 Jun; 80(7):1052-7. PubMed ID: 10362115
    [Abstract] [Full Text] [Related]

  • 2. A phase I dose finding study of a biweekly schedule of a fixed dose of cisplatin with increasing doses of paclitaxel in patients with advanced esophageal cancer.
    van der Gaast A, Kok TC, Vos R, Kerkhofs L, Splinter TA.
    Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-82-S19-85. PubMed ID: 9427273
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Phase I study of dose-escalated paclitaxel, ifosfamide, and cisplatin (PIC) combination chemotherapy in advanced solid tumours.
    Kosmas C, Tsavaris NB, Polyzos A, Malamos NA, Katsikas M, Antonopoulos MJ.
    Br J Cancer; 2000 Jan; 82(2):300-7. PubMed ID: 10646881
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Phase I trial of combined-modality therapy for localized esophageal cancer: escalating doses of continuous-infusion paclitaxel with cisplatin and concurrent radiation therapy.
    Brenner B, Ilson DH, Minsky BD, Bains MS, Tong W, Gonen M, Kelsen DP.
    J Clin Oncol; 2004 Jan 01; 22(1):45-52. PubMed ID: 14701767
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Phase II study of paclitaxel and cisplatin for advanced squamous-cell carcinoma of esophagus].
    Huang J, Cai RG, Meng PJ, Zhang MJ, Cui CX, Yang L, Chu DT, Sun Y, Wang JW.
    Zhonghua Zhong Liu Za Zhi; 2004 Dec 01; 26(12):753-5. PubMed ID: 15733398
    [Abstract] [Full Text] [Related]

  • 9. A dose-finding study of raltitrexed (tomudex) with cisplatin and epirubicin in advanced gastro-oesophageal adenocarcinoma.
    Eatock MM, Anthony DA, El-Abassi M, Wilson P, Paul J, Smith M, Soukop M, Evans TR.
    Br J Cancer; 2000 Jun 01; 82(12):1925-31. PubMed ID: 10864199
    [Abstract] [Full Text] [Related]

  • 10. Aggressive simultaneous radiochemotherapy with cisplatin and paclitaxel in combination with accelerated hyperfractionated radiotherapy in locally advanced head and neck tumors. Results of a phase I-II trial.
    Kuhnt T, Becker A, Pigorsch S, Pelz T, Bloching M, Passmann M, Lotterer E, Hänsgen G, Dunst J.
    Strahlenther Onkol; 2003 Oct 01; 179(10):673-81. PubMed ID: 14566475
    [Abstract] [Full Text] [Related]

  • 11. Phase I and pharmacologic study of a 3-hour infusion of paclitaxel followed by cisplatinum and 5-fluorouracil in patients with advanced solid tumors.
    Bhalla KN, Kumar GN, Walle UK, Ibrado AM, Javed T, Stuart RK, Reed C, Arbuck SG, Walle T.
    Clin Cancer Res; 1999 Jul 01; 5(7):1723-30. PubMed ID: 10430075
    [Abstract] [Full Text] [Related]

  • 12. Twice-daily radiotherapy as concurrent boost technique during two chemotherapy cycles in neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: mature results of phase II study.
    Choi N, Park SD, Lynch T, Wright C, Ancukiewicz M, Wain J, Donahue D, Mathisen D.
    Int J Radiat Oncol Biol Phys; 2004 Sep 01; 60(1):111-22. PubMed ID: 15337546
    [Abstract] [Full Text] [Related]

  • 13. Phase II study of biweekly paclitaxel and cisplatin combination chemotherapy in advanced gastric cancer: Korea Japan Collaborative Study Group Trial.
    Kim YH, Yamaguchi K, Bang YJ, Takiuchi H, Kang WK, Sato A, Kang YK, Sakamoto J, Abe C, Sakata Y.
    Jpn J Clin Oncol; 2007 Jul 01; 37(7):501-8. PubMed ID: 17673470
    [Abstract] [Full Text] [Related]

  • 14. A study of weekly paclitaxel plus 5-fluorouracil and cisplatin for patients with advanced or recurrent inoperable gastric cancer.
    Gu Y, Shu Y, Xu Q.
    Biomed Pharmacother; 2009 May 01; 63(4):293-6. PubMed ID: 18848761
    [Abstract] [Full Text] [Related]

  • 15. Evidence for a schedule-dependent deleterious interaction between paclitaxel, vinblastine and cisplatin (PVC) in the treatment of advanced transitional cell carcinoma.
    Mulatero C, McClaren BR, Mason M, Oliver RT, Gallagher CJ.
    Br J Cancer; 2000 Dec 01; 83(12):1612-6. PubMed ID: 11104554
    [Abstract] [Full Text] [Related]

  • 16. First-line chemotherapy with weekly paclitaxel and carboplatin for advanced ovarian cancer: a phase I study.
    Sehouli J, Stengel D, Elling D, Ortmann O, Blohmer J, Riess H, Lichtenegger W, Ovarian Cancer Study Group of the Nordostdeutsche Gesellschaft für Gynäkologische Onkologie (NOGGO).
    Gynecol Oncol; 2002 May 01; 85(2):321-6. PubMed ID: 11972395
    [Abstract] [Full Text] [Related]

  • 17. Multi-center phase II trial of weekly paclitaxel plus cisplatin combination chemotherapy in patients with advanced gastric and gastro-esophageal cancer.
    Sun Q, Liu C, Zhong H, Zhong B, Xu H, Shen W, Wang D.
    Jpn J Clin Oncol; 2009 Apr 01; 39(4):237-43. PubMed ID: 19264768
    [Abstract] [Full Text] [Related]

  • 18. A phase I study of topotecan/paclitaxel alternating with etoposide/cisplatin and thoracic irradiation in patients with limited small cell lung cancer.
    Lu C, Komaki R, Lee JS, Shin DM, Palmer JL, Coldman BJ, Pisters KM, Kurie JM, Fossella FV, Glisson BS.
    Clin Cancer Res; 2003 Jun 01; 9(6):2085-91. PubMed ID: 12796372
    [Abstract] [Full Text] [Related]

  • 19. A phase I study of paclitaxel, cisplatin, and fluorouracil (TCF) for advanced gastric cancer.
    Hara T, Omura K, Hirano M, Asada Y, Munemoto Y, Sakamoto J.
    Cancer Chemother Pharmacol; 2007 Apr 01; 59(5):631-6. PubMed ID: 16924496
    [Abstract] [Full Text] [Related]

  • 20. Phase II trial of dose-dense paclitaxel, cisplatin, 5-fluorouracil, and leucovorin with filgrastim support in patients with squamous cell carcinoma of the head and neck.
    Hitt R, Jimeno A, Millán JM, Castellano D, Cortés-Funes H.
    Cancer; 2004 Aug 15; 101(4):768-75. PubMed ID: 15305408
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.